Baidu
map

苯诱导白血病可能与对造血干细胞毒性作用有关

2016-07-03 MedSci MedSci原创

在一项新的研究中,马来西亚科学家提供证据证实一种广泛使用的化学物要比其他的化学物对骨髓中的造血干细胞和造血祖细胞具有更强的毒性。苯是世界上最为广泛使用的化学物之一。它主要用于制造塑料、橡胶、染料、去污剂和杀虫剂等材料。它也能够在汽车尾气和工业烟气中发现到。它对血细胞的毒性作用已得到很好地记载,而且已知它导致不同类型的白血病、多发性骨髓瘤和非霍奇金淋巴瘤。然而,关于它的毒性作用的精确机制在此之前人们

在一项新的研究中,马来西亚科学家提供证据证实一种广泛使用的化学物要比其他的化学物对骨髓中的造血干细胞和造血祖细胞具有更强的毒性。

苯是世界上最为广泛使用的化学物之一。它主要用于制造塑料、橡胶、染料、去污剂和杀虫剂等材料。它也能够在汽车尾气和工业烟气中发现到。它对血细胞的毒性作用已得到很好地记载,而且已知它导致不同类型的白血病、多发性骨髓瘤和非霍奇金淋巴瘤。然而,关于它的毒性作用的精确机制在此之前人们并不清楚。

在这项研究中,来自马来西亚国民大学的研究人员基于之前的研究,证实苯是在肝脏中进行代谢的,随后它的代谢物在骨髓中经过进一步代谢后产生1,4-苯醌(1,4-benzoquinone, 缩写为1,4-BQ),其中已知1,4-BQ对血细胞是有毒性的。

研究人员在小鼠体内研究了1,4-BQ对造血干细胞(HSC)和造血祖细胞(haematopoietic progenitor cell, HPC)的影响,其中HSC是在骨髓中发现的,能够产生任何一种类型的血细胞,而骨髓中的每种HPC能够分化为仅仅一种特定类型的血细胞。

研究人员让小鼠中的这些骨髓细胞接触不同浓度的1,4-BQ,结果发现它诱导细胞毒性,从而导致自杀性细胞死亡,或者说细胞凋亡。他们也发现相比于T细胞淋巴祖细胞(T cell lymphoid progenitor),1,4-BQ对HSC、髓样祖细胞(myeloid progenitor,能够产生红细胞和血小板等)和B细胞淋巴祖细胞(B cell lymphoid progenitor)的毒性更大。他们也发现1,4-BQ对产生单种血细胞的造血祖细胞的毒性要比产生多种血细胞的造血祖细胞更大。

研究人员说,在此之前还没有一项研究比较过1,4-BQ暴露对不同造血祖细胞的毒性作用。

尽管苯本身可能对血细胞是没有毒性的,但是科学家们认为它的代谢物是有毒性的。研究人员说,这项研究提供一种实验性系统进一步理解苯代谢物如何破坏对造血干细胞的调节。


原始出处:

Chow PW, Abdul Hamid Z, Chan KM, Inayat-Hussain SH, Rajab NF. Lineage-related cytotoxicity and clonogenic profile of 1,4-benzoquinone-exposed hematopoieticstem and progenitor cells. Toxicol Appl Pharmacol. 2015 Apr 1;284(1):8-15.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2080955, encodeId=b6b620809555e, content=<a href='/topic/show?id=7ee76358125' target=_blank style='color:#2F92EE;'>#毒性作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63581, encryptionId=7ee76358125, topicName=毒性作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e4433, createdName=zz12341234, createdTime=Thu Dec 15 22:31:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271382, encodeId=40b512e138210, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95001, encryptionId=a0ff950018f, topicName=造血干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494513, encodeId=65d314945137f, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529506, encodeId=fbdb152950639, content=<a href='/topic/show?id=a02ce793707' target=_blank style='color:#2F92EE;'>#细胞毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77937, encryptionId=a02ce793707, topicName=细胞毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b211951227, createdName=appleandpeer, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91855, encodeId=31b0918556b, content=化学实验室啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Jul 04 09:00:00 CST 2016, time=2016-07-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2080955, encodeId=b6b620809555e, content=<a href='/topic/show?id=7ee76358125' target=_blank style='color:#2F92EE;'>#毒性作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63581, encryptionId=7ee76358125, topicName=毒性作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e4433, createdName=zz12341234, createdTime=Thu Dec 15 22:31:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271382, encodeId=40b512e138210, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95001, encryptionId=a0ff950018f, topicName=造血干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494513, encodeId=65d314945137f, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529506, encodeId=fbdb152950639, content=<a href='/topic/show?id=a02ce793707' target=_blank style='color:#2F92EE;'>#细胞毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77937, encryptionId=a02ce793707, topicName=细胞毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b211951227, createdName=appleandpeer, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91855, encodeId=31b0918556b, content=化学实验室啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Jul 04 09:00:00 CST 2016, time=2016-07-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2080955, encodeId=b6b620809555e, content=<a href='/topic/show?id=7ee76358125' target=_blank style='color:#2F92EE;'>#毒性作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63581, encryptionId=7ee76358125, topicName=毒性作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e4433, createdName=zz12341234, createdTime=Thu Dec 15 22:31:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271382, encodeId=40b512e138210, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95001, encryptionId=a0ff950018f, topicName=造血干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494513, encodeId=65d314945137f, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529506, encodeId=fbdb152950639, content=<a href='/topic/show?id=a02ce793707' target=_blank style='color:#2F92EE;'>#细胞毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77937, encryptionId=a02ce793707, topicName=细胞毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b211951227, createdName=appleandpeer, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91855, encodeId=31b0918556b, content=化学实验室啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Jul 04 09:00:00 CST 2016, time=2016-07-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2080955, encodeId=b6b620809555e, content=<a href='/topic/show?id=7ee76358125' target=_blank style='color:#2F92EE;'>#毒性作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63581, encryptionId=7ee76358125, topicName=毒性作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e4433, createdName=zz12341234, createdTime=Thu Dec 15 22:31:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271382, encodeId=40b512e138210, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95001, encryptionId=a0ff950018f, topicName=造血干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494513, encodeId=65d314945137f, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529506, encodeId=fbdb152950639, content=<a href='/topic/show?id=a02ce793707' target=_blank style='color:#2F92EE;'>#细胞毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77937, encryptionId=a02ce793707, topicName=细胞毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b211951227, createdName=appleandpeer, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91855, encodeId=31b0918556b, content=化学实验室啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Jul 04 09:00:00 CST 2016, time=2016-07-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2080955, encodeId=b6b620809555e, content=<a href='/topic/show?id=7ee76358125' target=_blank style='color:#2F92EE;'>#毒性作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63581, encryptionId=7ee76358125, topicName=毒性作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e4433, createdName=zz12341234, createdTime=Thu Dec 15 22:31:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271382, encodeId=40b512e138210, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95001, encryptionId=a0ff950018f, topicName=造血干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494513, encodeId=65d314945137f, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529506, encodeId=fbdb152950639, content=<a href='/topic/show?id=a02ce793707' target=_blank style='color:#2F92EE;'>#细胞毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77937, encryptionId=a02ce793707, topicName=细胞毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b211951227, createdName=appleandpeer, createdTime=Tue Jul 05 14:31:00 CST 2016, time=2016-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91855, encodeId=31b0918556b, content=化学实验室啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Jul 04 09:00:00 CST 2016, time=2016-07-04, status=1, ipAttribution=)]
    2016-07-04 sillywu

    化学实验室啊

    0

相关资讯

白血病精准医疗再进一步

中外科学家合作对急性B淋巴细胞白血病(B-ALL)的基因组学研究获得重大进展,全方位解析了该病的分子发病机理,为精准医学提供了新模式。相关研究成果近日发表于《E生物医学》。 B-ALL是一类常见急性白血病,多见于儿童,同时占成人急性白血病的20%。我国儿童B-ALL的长期生存率达到70%左右,但仍有20%~30%治疗失败,而成人长期生存率仅约20%。 联合课题组在国际上第一次应用全外显子组、全

Leukemia:中国科研人员发现治疗白血病新型抑制剂

记者6月19日从中国科学院强磁场科学中心获悉,该中心研究人员研发出一种新型白血病抑制剂CHMFL-FLT3-165,且具有自主知识产权。在临床动物模型实验中,该抑制剂可以减缓FLT3-ITD阳性急性髓细胞性白血病肿瘤在小鼠体内的增长。 该研究成果近日在线发表在国际著名学术期刊《白血病》上,并分别申请了中国发明专利和国际PCT专利申请的保护。 急性髓细胞性白血病(AML)是成年人血液系统常见的恶

JCO:ALL患儿可根据MRD情况选择合适的化疗

荷兰儿童肿瘤协作组的研究结果称,检测不到微小残留病(MRD)的急性淋巴细胞白血病(ALL)患者,接受低剂量化疗不会影响到其生存。 荷兰王妃马克西玛儿科肿瘤中心的首席医疗官Rob Pieters博士对778名患者进行了研究,其中686人在一线或二线化疗后,根据MRD,被分层为标准风险组(n = 198)、中间风险组(n = 460)或高风险组(n = 28)。标准组的患者化疗减少,而在中高风险

Nature:靶向攻击p53和c-MYC可选择性清除白血病干细胞

在一项新的研究中,来自英国格拉斯哥大学、曼彻斯特大学和澳大利亚墨尔本大学的一个跨学科研究团队揭示出慢性粒细胞白血病(chronic myeloid leukaemia, CML)的阿喀琉斯之踵(即致命弱点),并且发现在小鼠体内成功地靶向攻击这种弱点和根除这种疾病的药物。相关研究结果于2016年6月8日在线发表在Nature期刊上,论文标题为“Dual targeting of p53 and

STM:birinapant和emricasan新的药物组合在治疗白血病上显示成功的希望

急性骨髓白血病(AML)患者,可以期待研发的新疗法。 沃尔特和伊莱扎霍尔研究所的研究人员发现,杀死有害细胞繁殖的新方法。 细胞有一个称为细胞凋亡(程序性细胞死亡)的过程——这是一种自然和必要的反应,以保持人类细胞受控制的增殖。癌细胞,包括AML,是没有这一过程的,结果是细胞不受控制的生长。 由研究所的John Silke教授和墨尔本默多克儿童研究所Paul Ekert教授领导的研究团队,团队

Blood:什么让白血病死灰复燃?

研究人员首次发现,在化疗过程中,某些白血病细胞能获得来自正常细胞的能源资源,从而在治疗后不仅帮助癌细胞生存,而且帮助它们繁荣发展。 这项研究发表在今天的《Blood》杂志,重点是急性髓系白血病(AML)——一种血液和骨髓癌,是在成人中最常见的急性白血病类型。根据美国癌症协会资料显示,在美国每年有近20000名成年人患有AML,另有10400人死于这种疾病。尽管在最初进行化疗通常可成功对抗这种

Baidu
map
Baidu
map
Baidu
map